23.01.2017 07:38 Uhr, Quelle: FinanzNachrichten.de

Press Release: Actelion announces results of the MAESTRO study with macitentan in patients with pulmonary arterial hypertension due to Eisenmenger Syndrome

Actelion Pharmaceuticals Ltd / Actelion announces results of the MAESTRO study with macitentan in patients with pulmonary arterial hypertension due to Eisenmenger Syndrome . Processed and transmit

Weiterlesen bei FinanzNachrichten.de